| CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients T Skillbäck, L Delsing, J Synnergren, N Mattsson, S Janelidze, K Nägga, ... Neurobiology of aging 59, 1-9, 2017 | 119 | 2017 |
| Human iPS-derived astroglia from a stable neural precursor state show improved functionality compared with conventional astrocytic models A Lundin, L Delsing, M Clausen, P Ricchiuto, J Sanchez, A Sabirsh, ... Stem cell reports 10 (3), 1030-1045, 2018 | 112 | 2018 |
| Barrier properties and transcriptome expression in human iPSC-derived models of the blood–brain barrier L Delsing, P Dönnes, J Sánchez, M Clausen, D Voulgaris, A Falk, ... Stem cells 36 (12), 1816-1827, 2018 | 111 | 2018 |
| Models of the blood-brain barrier using iPSC-derived cells L Delsing, A Herland, A Falk, R Hicks, J Synnergren, H Zetterberg Molecular and Cellular Neuroscience 107, 103533, 2020 | 64 | 2020 |
| Truncation of the TAR DNA-binding protein 43 is not a prerequisite for cytoplasmic relocalization, and is suppressed by caspase inhibition and by introduction of the A90V … HJ Wobst, L Delsing, NJ Brandon, SJ Moss PLoS One 12 (5), e0177181, 2017 | 31 | 2017 |
| Cytoplasmic Relocalization of TAR DNA-Binding Protein 43 Is Not Sufficient to Reproduce Cellular Pathologies Associated with ALS In vitro HJ Wobst, SS Wesolowski, J Chadchankar, L Delsing, S Jacobsen, ... Frontiers in molecular neuroscience 10, 46, 2017 | 31 | 2017 |
| Utilizing microphysiological systems and induced pluripotent stem cells for disease modeling: a case study for blood brain barrier research in a pharmaceutical setting KM Fabre, L Delsing, R Hicks, N Colclough, DC Crowther, L Ewart Advanced Drug Delivery Reviews 140, 129-135, 2019 | 24 | 2019 |
| Enhanced xeno-free differentiation of hiPSC-derived astroglia applied in a blood–brain barrier model L Delsing, T Kallur, H Zetterberg, R Hicks, J Synnergren Fluids and Barriers of the CNS 16, 1-15, 2019 | 11 | 2019 |
| Cytoplasmic Relocalization of TAR DNA-Binding Protein 43 Is Not Sufficient to Reproduce Cellular Pathologies Associated with ALS In vitro. Front Mol Neurosci. 2017; 10: 46 HJ Wobst, SS Wesolowski, J Chadchankar, L Delsing, S Jacobsen, ... Epub 2017/03/14. https://doi. org/10. 3389/fnmol. 2017.00046 PMID: 28286471, 0 | 5 | |
| International evaluation study of a highly efficient culture assay for detection of residual human pluripotent stem cells in cell therapies T Watanabe, S Yasuda, CL Chen, L Delsing, MD Fellows, G Foldes, ... Regenerative Medicine 18 (3), 219-227, 2023 | 4 | 2023 |
| Immune safety challenges facing the preclinical assessment and clinical progression of cell therapies SM Bates, KV Evans, L Delsing, R Wong, G Cornish, M Bahjat Drug Discovery Today, 104239, 2024 | | 2024 |
| Application of microphysiological systems for nonclinical evaluation of cell therapies PL Candarlioglu, L Delsing, L Gauthier, L Lewis, G Papadopoulos, ... ALTEX-Alternatives to animal experimentation 41 (3), 469-484, 2024 | | 2024 |
| In vitro models of the blood brain-barrier using iPSC-derived cells L Delsing | | 2019 |
| Plasminogen binding inhibitors demonstrate unwanted activities on GABAA and glycine receptors in human iPSC derived neurons L Kristensson, A Lundin, D Gustafsson, J Fryklund, T Fex, L Delsing, ... Neuroscience Letters 681, 37-43, 2018 | | 2018 |
| Mei Ding, Jane Synnergren, 6 Henrik Zetterberg, 7, 8, 9, 10 Gabriella Brolén, Ryan Hicks, Anna Herland, 4, 5,* and Anna Falk 3 A Lundin, L Delsing, M Clausen, P Ricchiuto, J Sanchez, A Sabirsh | | |
